Literature DB >> 36045222

Simultaneous metabolite MALDI-MSI, whole exome and transcriptome analysis from formalin-fixed paraffin-embedded tissue sections.

Julia Hess1,2,3, Kristian Unger4,5,6, Lisa Kreutzer1,2, Peter Weber1,2, Theresa Heider1,2, Mathias Heikenwälder7, Tobias Riedl7, Philipp Baumeister8, Frederick Klauschen9, Claus Belka2,3,10, Axel Walch11, Horst Zitzelsberger1,2,3.   

Abstract

Matrix-assisted laser desorption ionization mass spectrometry imaging (MALDI-MSI) allows spatial analysis of proteins, metabolites, or small molecules from tissue sections. Here, we present the simultaneous generation and analysis of MALDI-MSI, whole-exome sequencing (WES), and RNA-sequencing data from the same formalin-fixed paraffin-embedded (FFPE) tissue sections. Genomic DNA and total RNA were extracted from (i) untreated, (ii) hematoxylin-eosin (HE) stained, and (iii) MALDI-MSI-analyzed FFPE tissue sections from three head and neck squamous cell carcinomas. MALDI-MSI data were generated by a time-of-flight analyzer prior to preprocessing and visualization. WES data were generated using a low-input protocol followed by detection of single-nucleotide variants (SNVs), tumor mutational burden, and mutational signatures. The transcriptome was determined using 3'-RNA sequencing and was examined for similarities and differences between processing stages. All data met the commonly accepted quality criteria. Besides SNVs commonly identified between differently processed tissues, FFPE-typical artifactual variants were detected. Tumor mutational burden was in the same range for tissues from the same patient and mutational signatures were highly overlapping. Transcriptome profiles showed high levels of correlation. Our data demonstrate that simultaneous molecular profiling of MALDI-MSI-processed FFPE tissue sections at the transcriptome and exome levels is feasible and reliable.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 36045222     DOI: 10.1038/s41374-022-00829-0

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.502


  17 in total

1.  Digital PCR After MALDI-Mass Spectrometry Imaging to Combine Proteomic Mapping and Identification of Activating Mutations in Pulmonary Adenocarcinoma.

Authors:  Daniel Kazdal; Rémi Longuespée; Steffen Dietz; Rita Casadonte; Kristina Schwamborn; Anna-Lena Volckmar; Jörg Kriegsmann; Katharina Kriegsmann; Margaux Fresnais; Albrecht Stenzinger; Holger Sültmann; Arne Warth; Mark Kriegsmann
Journal:  Proteomics Clin Appl       Date:  2018-10-15       Impact factor: 3.494

Review 2.  Coming of age: ten years of next-generation sequencing technologies.

Authors:  Sara Goodwin; John D McPherson; W Richard McCombie
Journal:  Nat Rev Genet       Date:  2016-05-17       Impact factor: 53.242

3.  Multimodal analysis of formalin-fixed and paraffin-embedded tissue by MALDI imaging and fluorescence in situ hybridization for combined genetic and metabolic analysis.

Authors:  Katharina Huber; Thomas Kunzke; Achim Buck; Rupert Langer; Birgit Luber; Annette Feuchtinger; Axel Walch
Journal:  Lab Invest       Date:  2019-05-31       Impact factor: 5.662

Review 4.  In Situ Metabolomics in Cancer by Mass Spectrometry Imaging.

Authors:  A Buck; M Aichler; K Huber; A Walch
Journal:  Adv Cancer Res       Date:  2016-12-20       Impact factor: 6.242

Review 5.  Integrative omics for health and disease.

Authors:  Konrad J Karczewski; Michael P Snyder
Journal:  Nat Rev Genet       Date:  2018-02-26       Impact factor: 53.242

Review 6.  Integrative radiation systems biology.

Authors:  Kristian Unger
Journal:  Radiat Oncol       Date:  2014-01-11       Impact factor: 3.481

Review 7.  Multi-omics approaches to disease.

Authors:  Yehudit Hasin; Marcus Seldin; Aldons Lusis
Journal:  Genome Biol       Date:  2017-05-05       Impact factor: 13.583

Review 8.  Onco-Multi-OMICS Approach: A New Frontier in Cancer Research.

Authors:  Sajib Chakraborty; Md Ismail Hosen; Musaddeque Ahmed; Hossain Uddin Shekhar
Journal:  Biomed Res Int       Date:  2018-10-03       Impact factor: 3.411

9.  Precise co-registration of mass spectrometry imaging, histology, and laser microdissection-based omics.

Authors:  Frédéric Dewez; Marta Martin-Lorenzo; Michael Herfs; Dominique Baiwir; Gabriel Mazzucchelli; Edwin De Pauw; Ron M A Heeren; Benjamin Balluff
Journal:  Anal Bioanal Chem       Date:  2019-07-01       Impact factor: 4.142

10.  Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients.

Authors:  Steffen Dietz; Uwe Schirmer; Clémentine Mercé; Nikolas von Bubnoff; Edgar Dahl; Michael Meister; Thomas Muley; Michael Thomas; Holger Sültmann
Journal:  PLoS One       Date:  2016-08-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.